Dipnath is mostly interested in creating new businesses, products, and alliances in non-pharmaceutical applications. Use of Codexis enzyme engineering technology to enable new products and/or improve current products as a principal value-add is central to this strategy. Dipnath also governs strategic alliances at Codexis including all technology license partnerships. He started his professional career with 1 y at Dow Chemical Company followed by 16 y at Codexis. His PhD is in microbiology.